| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1099715753 |
| P356 | DOI | 10.1038/MI.2017.107 |
| P698 | PubMed publication ID | 29346350 |
| P50 | author | Jun Shen | Q79576820 |
| Hong-Yue Jiang | Q88410220 | ||
| P2093 | author name string | Z Ran | |
| P2860 | cites work | Colorectal cancer and Crohn's colitis: clinical implications from 313 surgical patients. | Q50874294 |
| Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort. | Q51026199 | ||
| Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. | Q53547282 | ||
| mTOR inhibitors for medical treatment of post-transplantation encapsulating peritoneal sclerosis: a favourable single center experience. | Q53638795 | ||
| Differential modulation of the cytokine-induced MMP-9/TIMP-1 protease-antiprotease system by the mTOR inhibitor rapamycin. | Q54648889 | ||
| Carcinoma of the small intestine and colon as a complication of Crohn disease: radiologic manifestations | Q71265007 | ||
| The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease | Q74262625 | ||
| The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota | Q77810598 | ||
| Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase | Q79249628 | ||
| Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study | Q80135540 | ||
| Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis | Q80178424 | ||
| Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation | Q81398566 | ||
| Interleukin-13 and transforming growth factor β synergise in the pathogenesis of human intestinal fistulae | Q83355378 | ||
| Potential role for SNAIL family transcription factors in the etiology of Crohn's disease-associated fistulae | Q84735706 | ||
| Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn's disease | Q86857973 | ||
| Guidelines for the management of inflammatory bowel disease in adults | Q22242049 | ||
| Epithelial-mesenchymal transition and its implications for fibrosis | Q24302042 | ||
| Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors | Q24312920 | ||
| TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function | Q24314628 | ||
| A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells | Q24649109 | ||
| The basics of epithelial-mesenchymal transition | Q24652992 | ||
| Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD | Q26740540 | ||
| Molecular mechanisms of epithelial-mesenchymal transition | Q27013743 | ||
| Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
| Pattern recognition receptors and inflammation | Q27861115 | ||
| The multidisciplinary health care team in the management of stenosis in Crohn's disease | Q28088702 | ||
| Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models | Q28201247 | ||
| Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton | Q28235021 | ||
| Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies | Q28241091 | ||
| The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it | Q28254798 | ||
| The transcriptional repressor Snail promotes mammary tumor recurrence | Q28272823 | ||
| IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis | Q28285105 | ||
| Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis | Q28578937 | ||
| Many roads to maturity: microRNA biogenesis pathways and their regulation | Q29615469 | ||
| Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
| TGF-beta-induced epithelial to mesenchymal transition | Q29619820 | ||
| Mechanisms of fibrosis: therapeutic translation for fibrotic disease | Q29620307 | ||
| Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development | Q30311953 | ||
| Dkk-1 inhibits intestinal epithelial cell migration by attenuating directional polarization of leading edge cells | Q30491669 | ||
| Organoid-based epithelial to mesenchymal transition (OEMT) model: from an intestinal fibrosis perspective | Q30853689 | ||
| Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated | Q33656926 | ||
| Specific differences in migratory function of myofibroblasts isolated from Crohn's disease fistulae and strictures | Q33694536 | ||
| Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma | Q33731789 | ||
| Origin and function of myofibroblasts in kidney fibrosis | Q33792700 | ||
| Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. | Q33799732 | ||
| Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2. | Q33816329 | ||
| Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition | Q33868704 | ||
| Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. | Q33924416 | ||
| Slug and Sox9 cooperatively determine the mammary stem cell state | Q34030957 | ||
| Distinct EMT programs control normal mammary stem cells and tumour-initiating cells | Q34044818 | ||
| Pathophysiology of fistula formation in Crohn's disease | Q34047996 | ||
| Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort | Q34175981 | ||
| Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7. | Q34289774 | ||
| The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis. | Q34358154 | ||
| Early role of Fsp1 in epithelial-mesenchymal transformation | Q34445512 | ||
| Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review | Q34504710 | ||
| Cessation of gastrulation is mediated by suppression of epithelial-mesenchymal transition at the ventral ectodermal ridge. | Q34713707 | ||
| Long-term efficacy of infliximab maintenance therapy for perianal Crohn's disease | Q34717423 | ||
| The gut microbiome in intestinal fibrosis: environmental protector or provocateur? | Q34778411 | ||
| Epithelial-mesenchymal transitions: a mesodermal cell strategy for evolutive innovation in Metazoans. | Q34969022 | ||
| The role for dickkopf-homolog-1 in the pathogenesis of Crohn's disease-associated fistulae | Q35046650 | ||
| Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. | Q35147482 | ||
| Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis | Q35261897 | ||
| Morphological characterisation of Crohn's disease fistulae | Q35596840 | ||
| Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention | Q35615604 | ||
| A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis | Q35669295 | ||
| Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis | Q35688448 | ||
| Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis | Q35749152 | ||
| Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders | Q35797879 | ||
| Microbes-induced EMT at the crossroad of inflammation and cancer | Q36187673 | ||
| Targeting the TGFβ signalling pathway in disease | Q36462348 | ||
| Implantation of the human embryo: research lines and models. From the implantation research network 'Fruitful'. | Q36512065 | ||
| miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells | Q36733168 | ||
| Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction | Q36991087 | ||
| The differential expression of TGF-β1, ILK and wnt signaling inducing epithelial to mesenchymal transition in human renal fibrogenesis: an immunohistochemical study | Q37137981 | ||
| A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition | Q37162704 | ||
| Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. | Q37278443 | ||
| Intestinal fibrosis in IBD--a dynamic, multifactorial process | Q37433780 | ||
| Utility of a bacterial infection model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or tumorigenesis. | Q37445364 | ||
| Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. | Q37504561 | ||
| Fistula-associated anal adenocarcinoma in Crohn's disease | Q37699089 | ||
| Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis | Q37707603 | ||
| An evidence-based systematic review on medical therapies for inflammatory bowel disease | Q37862584 | ||
| Hospitalisations and surgery in Crohn's disease | Q37977910 | ||
| Cadherin recognition and adhesion. | Q38024463 | ||
| Implication of miRNAs for inflammatory bowel disease treatment: Systematic review | Q38217235 | ||
| A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease. | Q38222052 | ||
| Origin of myofibroblasts and cellular events triggering fibrosis | Q38243843 | ||
| Biologic agents for IBD: practical insights | Q38568898 | ||
| The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL. | Q38774043 | ||
| MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases | Q39028929 | ||
| Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication | Q39113709 | ||
| Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1/2 inhibitor | Q39552177 | ||
| LPS-Induced Epithelial-Mesenchymal Transition of Intrahepatic Biliary Epithelial Cells | Q39670112 | ||
| Transforming growth factor-beta1 represses E-cadherin production via slug expression in lens epithelial cells | Q40128100 | ||
| Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. | Q40200816 | ||
| Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. | Q40660373 | ||
| Colorectal adenocarcinoma in Crohn's disease | Q40967940 | ||
| Healing the epithelium: solving the problem from two sides | Q41371678 | ||
| miR-200b is involved in intestinal fibrosis of Crohn's disease | Q41848371 | ||
| Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease | Q42128613 | ||
| Formation and migration of neural crest cells in the vertebrate embryo | Q42288292 | ||
| Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. | Q42660509 | ||
| Regulation of migration of human colonic myofibroblasts | Q44083087 | ||
| BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury | Q44479221 | ||
| Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark | Q44776677 | ||
| Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease | Q44898872 | ||
| A role for tumor necrosis factor and bacterial antigens in the pathogenesis of Crohn's disease-associated fistulae | Q44971946 | ||
| TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis | Q46391244 | ||
| Use of sirolimus (rapamycin) to treat refractory Crohn's disease | Q46417377 | ||
| A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease | Q46451550 | ||
| Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. | Q46547661 | ||
| Everolimus for refractory Crohn's disease: a case report | Q46753802 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 294-303 | |
| P577 | publication date | 2017-12-20 | |
| P1433 | published in | Mucosal Immunology | Q15817743 |
| P1476 | title | Epithelial-mesenchymal transition in Crohn's disease | |
| P478 | volume | 11 |
| Q98291712 | Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients |
| Q58782783 | Total flavone of suppresses epithelial-mesenchymal transition interfering transforming growth factor-β1 signaling in Crohn's disease intestinal fibrosis |
Search more.